Synthesis,physicochemical characterization,geometric structure and molecular docking of new biologically active ferrocene based Schiff base ligand with transition metal ions

Physicochemical studies were performed to study new ferrocene based Schiff base ligand (HL), (Z)‐(4‐(1‐((2‐carboxycyclohexa‐2,4‐dien‐1‐yl)imino)ethyl)[bis(η ⁵ cyclopenta‐1,3‐dien‐1 yl)]iron with some transition metal ions to form a series of ferrocenyl derivatives bearing transition metal complexes of the type [M(L)Cl(H₂O)₃] (M = Ni(II), Cu(II)), [M(L)Cl(H₂O)₃]nH₂O (M = Mn(II) (n = 1), Co(II) (n = 1), Zn(II) (n = 2) and Cd(II) (n = 3)) and [M(L)Cl(H₂O)₃]Cl.nH₂O (M = Cr(III) (n = 2) and Fe(III) (n = 1)). The new ligand and metal ion complexes have been prepared and characterized by IR, UV‐Vis, ¹H‐NMR, TG/DTA, elemental analysis and mass spectrometry. The TGA/DTG analysis revealed that the ferrocene precursors decompose spontaneously to form iron(II) oxide. The molecular and electronic structure of the ligand (HL) was optimized theoretically and the quantum chemical parameters were calculated. The molecular structure with a variety of functionalities can be used to investigate the coordination sites and the total charge density around each atom. DFT‐based molecular orbital energy calculations of the new ligand have been also studied. All of the complexes were screened against a panel of Gram (+) bacteria: Streptococcus pneumoniae and Bacillis subtilis , Gram (−) bacteria: Pseudomonas aeruginosa and Escherichia coli and panel of fungi: Aspergillus fumigatu , Syncephalastrum racemosum , Geotricum candidum and Candida albicans . Anticancer activity screening for the tested compounds using 4 different concentrations of HL ligand against human tumor cells of breast cancer cell line MCF‐7 were obtained. Molecular docking was used to predict the binding between HL ligand and human‐DNA‐Topo I complex (PDB ID: 1SC7), the receptors of breast cancer mutant oxidoreductase (PDB ID: 3HB5), crystal structure of Escherichia coli (PDB ID: 3T88), to identify the binding mode and the crucial functional groups interacting with the three proteins.     

Synthesis,characterization, and biological activity of some transition metal complexes with Schiff base ligands derived from 4-amino-5-phenyl-4<Emphasis Type="Italic">H</Emphasis>-1,2,4-triazole-3-thiol and salicaldehyde

Abstract  

The coordination behaviour of a Schiff base with SNO donation sites, derived from condensation of 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol and salicaldehyde, towards some bi- and trivalent metal ions, namely Cr(III), Mn(II), Fe(III), Co(II) (Cl, ClO₄), Ni(II) (Cl, ClO₄), Cu(II), and Zn(II), is reported. The metal complexes were characterized on the basis of elemental analysis, IR, ¹H NMR, solid reflectance, magnetic moment, molar conductance, and thermal analyses (TG, DTG, and DTA). The ionization constant of the Schiff base under investigation and the stability constants of its metal chelates were calculated pH-metrically at 25 °C and ionic strength μ = 0.1 M in 50% (v/v) ethanol–water mixture. The chelates were found to have octahedral (Mn(II)), trigonal bipyramidal (Co(II), Ni(II), Zn(II)), and tetrahedral (Cr(III), Fe(III), and Cu(II)) structures. The ligand and its binary chelates were subjected to thermal analyses and the different thermodynamic activation parameters were calculated from their corresponding DTG curves to throw more light on the nature of changes accompanying the thermal decomposition process of these compounds. The free Schiff base ligand and its metal complexes were tested in vitro against Aspergillus flavus, Candida albicans, C. tropicalis, and A. niger fungi and Bacillus subtilis and Escherichia coli bacteria in order to assess their antimicrobial potential. The results indicate that the ligand and its metal complexes possess antimicrobial properties.     

Inner metal complexes of tetradentate Schiff base: Synthesis,characterization, biological activity and molecular docking studies

A novel Schiff base ligand, namely 2,2′‐((1E,1′E)‐(1,3‐phenylenebis(azanylylidene))bis(methanylylidene))diphenol (H₂L), was synthesized by condensation of m‐phenylenediamine and 2‐hydroxybenzaldehyde (in 1:2 ratio). Series of complexes were obtained from the reaction of La(III), Er(III) and Yb(III) chlorides with H₂L. The ligand and complexes were characterized using elemental analysis, infrared, ¹H NMR, UV–visible and mass spectroscopies, magnetic susceptibility and conductivity measurements and thermal analysis. Infrared and ¹H NMR spectra indicated the coordination of the azomethine nitrogens and deprotonated phenolic oxygen atoms in a tetradentate manner (ONNO). The thermal behaviour of the complexes was studied from ambient temperature to 1000°C. The complexes were found to have water molecules of hydration and coordinated water molecules. The complexes were found to possess high biological activities against various organisms compared to the free ligand (Gram‐positive bacteria Staphylococcus aureus and Bacillus subtilis, Gram‐negative bacteria Salmonella sp., Escherichia coli and Pseudomonas aeruginosa and fungi Aspergillus fumigatus and Candida albicans). The more effective and probable binding modes between H₂L with different active sites of colon cancer (PDB code: 2hq6) and lung cancer (PDB code: 1x2j) receptors were investigated using molecular docking studies.     

Novel Schiff base ligand and its metal complexes with some transition elements. Synthesis,spectroscopic, thermal analysis,antimicrobial and in vitro anticancer activity

A novel Schiff base ligand (H₂L) was prepared through condensation of 2,6‐diaminopyridine and o‐benzoylbenzoic acid in a 1:2 ratio. This Schiff base ligand was characterized using elemental and spectroscopic analyses. A new series of Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) metal complexes of H₂L were prepared and characterized using elemental analysis, spectroscopy (¹H NMR, mass, UV–visible, Fourier transform infrared, electron spin resonance), magnetic susceptibility, molar conductivity, X‐ray powder diffraction and thermal analysis. The complexes are found to have trigonal bipyramidal geometry except Cr(III), Mn(II) and Fe(III) complexes which have octahedral geometry based on magnetic moment and solid reflectance measurements. The infrared spectral studies reveal that H₂L behaves as a neutral bidentate ligand and coordinates to the metal ions via the two azomethine nitrogens. ¹H NMR spectra confirm the non‐involvement of the carboxylic COOH proton in complex formation. The presence of water molecules in all reported complexes is supported by thermogravimetric studies. Kinetic and thermodynamic parameters were determined using Coats–Redfern and Horowitz–Metzger equations. The synthesized ligand and its complexes were screened for antimicrobial activities against two Gram‐positive bacteria (Bacillus subtilis and Staphylococcus aureus), two Gram‐negative bacteria (Escherichia coli and Neisseria gonorrhoeae) and one fungus (Candida albicans). Anticancer activities of the ligand and its metal complexes against human breast cancer cell line (MCF7) were investigated. Copyright © 2016 John Wiley & Sons, Ltd.     

Molecular structure,molecular docking,thermal, spectroscopic and biological activity studies of bis‐Schiff base ligand and its metal complexes

Coordination compounds of Fe(III), Zn(II), Ni(II), Co(II), Cu(II), Cd(II) and Mn(II) ions were synthesized from the ligand [4,4′‐((((ethane‐1,2‐diylbis(oxy))bis(2,1‐phenylene))bis(methanylylidene))bis(azanylylidene))diphenol]ethane (H₂L) derived from the condensation of bisaldehyde and 4‐aminophenol. Microanalysis, magnetic susceptibility, infrared, ¹H NMR and mass spectroscopies, molar conductance, X ray powder diffraction and thermal analysis were used to confirm the structure of the synthesized chelates. According to the data obtained, the composition of the 1:1 metal ion–bis‐Schiff base ligand was found to be [M(H₂L)(H₂O)₂]Cl_n (M = Zn(II), Ni(II), Co(II), Cu(II), Cd(II) and Mn(II), n = 2; Fe(III), n = 3). Magnetic susceptibility measurements and reflectance spectra suggested an octahedral geometry for the complexes. Central metals ions and bis‐Schiff base coordinated together via O2 and N2 donor sites which as evident from infrared spectra. The Gaussian09 program was applied to optimize the structural formula for the investigated Schiff base ligand. The energy gaps and other important theoretical parameters were calculated applying the DFT/B3LYP method. Molecular docking using AutoDock tools was utilized to explain the experimental behaviour of the Schiff base ligand towards proteins of Bacillus subtilis (5 h67), Escherichia coli (3 t88), Proteus vulgaris (5i39) and Staphylococcus aureus (3ty7) microorganisms through theoretical calculations. The docked protein receptors were investigated and the energies of hydrogen bonding were calculated. These complexes were then subjected to in vitro antibacterial studies against several organisms, both Gram negative (P. vulgaris and E. coli) and Gram positive (S. pyogones and B. subtilis). The ligand and metal complexes exhibited good microbial activity against the Gram‐positive and Gram‐negative bacteria.     

Physicochemical characterization of nanobidentate ferrocene‐based Schiff base ligand and its coordination complexes: Antimicrobial,anticancer, density functional theory,and molecular operating environment studies

A novel bidentate Schiff base ligand (HL, Nanobidentate Ferrocene based Schiff base ligand L (has one replaceable proton H)) was prepared via the condensation of 2‐amino phenol with 2‐acetyl ferrocene. The ligand was characterized using elemental analysis, mass spectrometry, infrared (IR) spectroscopy, ¹proton nuclear magnetic resonance (H‐NMR) spectroscopy, scanning electron microscopy (SEM), and thermal analysis. The corresponding 1:1 metal complexes with some transition‐metal ions were additionally characterized by their elemental analysis, molar conductance, SEM, and thermogravimetric ana1ysis (TGA). The complexes had the general formula [M(L)(Cl)(H₂O)₃]xCl·nH₂O (M = Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II)), (x = 0 for Mn(II), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II), x = 1 for Cr(III) and Fe(III)), (n = 1 for Cr(III), n = 3 for Mn(II) and Co(II), n = 4 for Fe(III), Ni(II), Cu(II), Zn(II), and Cd(II)). Density functional theory calculations on the HL ligand were also carried out in order to clarify molecular structures by the B31YP exchange‐correlation function. The results were subjected to molecular orbital diagram, highest occupied mo1ecu1ar orbital–lowest occupied molecular orbital, and molecular electrostatic potential calculations. The parent Schiff base and its eight metal complexes were assayed against four bacterial species (two Gram‐negative and two‐Gram positive) and four different antifungal species. The HL ligand was docked using molecular operating environment 2008 with crystal structures of oxidoreductase (1CX2), protein phosphatase of the fungus Candida albicans (5JPE), Gram(?) bacteria Escherichia coli (3T88), Gram(+) bacteria Staphylococcus aureus (3Q8U), and an androgen‐independent receptor of prostate cancer (1GS4). In order to assess cytotoxic nature of the prepared HL ligand and its complexes, the compounds were screened against the Michigan cancer foundation (MCF)‐7 breast cancer cell line, and the IC₅₀ values of compounds were calculated.     

Some divalent metal(II) complexes of novel potentially tetradentate Schiff base N,N′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde: Synthesis,spectroscopic characterization and bioactivities

A novel tetradentate dianionic Schiff base ligand, N ,N ′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde (H₂L) and some first row d‐transition metal chelates (Co(II), Cu(II), Ni(II) and Zn(II)) were synthesized and characterized using various physicochemical and spectroscopic methods. The spectroscopic data suggested that the parent Schiff base ligand coordinates through both deprotonated carboxylic oxygen and imine nitrogen atoms. The free Schiff base and its metal chelates were screened for their antimicrobial activities for various pathogenic bacteria and fungi using the agar well diffusion method. The antibacterial and antifungal activities of all the newly synthesized compounds are significant compared to the standard drugs ciprofloxacin and nystatin. The antioxidant activities of the compounds were determined by reduction of 1,1‐diphenyl‐2‐picrylhydrazyl and compared with that of vitamin C as a standard. DNA binding ability of the novel Schiff base and its complexes was investigated using absorption spectroscopy, fluorescence spectroscopy, viscosity measurements and thermal denaturation. The obtained results clearly demonstrate that the binding affinity with calf thymus DNA follows the order: Cu(II) complex > Ni(II) complex > Zn(II) complex > Co(II) complex >H₂L. Furthermore, the DNA cleavage activity of the newly synthesized ligand and its metal complexes was investigated using supercoiled plasmid DNA (pUC18) gel electrophoresis.     

Antimicrobial and anticancer activities of Schiff base ligand and its transition metal mixed ligand complexes with heterocyclic base

A new Schiff base ligand (HL) was prepared via a condensation reaction of quinoline‐2‐carboxaldhyde with 2‐aminophenol in a molar ratio of 1:1. Its transition metal mixed ligand complexes with 1,10‐phenanthroline (1,10‐phen) as co‐ligand were also synthesized in a 1:1:1 ratio. HL and its mixed ligand complexes were characterized using elemental analysis, infrared, ¹H NMR, mass and UV–visible spectroscopies, molar conductance, magnetic measurements, solid reflectance, thermal analysis, electron spin resonance and X‐ray diffraction. Molar conductance measurements showed that all complexes have an electrolytic nature, except Cd(II) complex. From elemental and spectral data, the formulae [M(L)(1,10‐phen)(H₂O)]Cl_x?nH₂O (where M = Cr(III) (x = n = 2), Mn(II) and Ni(II) (x = 1, n = 2), Fe(III) (x = n = 2), Co(II), Cu(II) and Zn(II) (x = 1, n = 2)) and [Cd(L)(1,10‐phen)Cl]?3H₂O for the metal complexes have been proposed. The geometric structures of complexes were found to be octahedral. Powder X‐ray diffraction reflected the crystalline nature of the complexes; however, the Schiff base is amorphous. HL and its mixed ligand complexes were screened against Gram‐positive bacteria (Streptococcus pneumoniae and Bacillus subtilis) and Gram‐negative bacteria (Pseudomonas aeruginosa and Escherichia coli). Antifungal activity was determined against Aspergillus fumigatus and Candida albicans, the data showing that most complexes had activity less than that of the Schiff base while Mn(II), Fe(III) and Ni(II) complexes showed no significant antifungal activity. The anticancer activity of HL and its metal complexes was also studied against breast and colon cell lines. The metal complexes showed IC₅₀ higher than that of HL, especially the Cu(II) complex which showed the highest IC₅₀ against breast cell line.     

New nanobidentate Schiff base ligand of 2-aminophenol with 2-acetyl ferrocene with some lanthanide metal ions: synthesis,characterization and Hepatitis A,B, C and breast cancer docking studies

Three lanthanide complexes (La(III), Er(III), and Yb(III)) derived from ferrocene-based Schiff base ligand (HL) were synthesized from condensation of 2-aminophenol with 2-acetylferrocene. The ligand and metal complexes were characterized based on elemental analyses, IR, ¹H NMR, molar conductance, SEM and thermal analyses (TG, DTG). The molar conductance revealed that all the metal chelates were electrolytes having the general composition [M(L)(Cl)(H₂O)₃]Cl·4H₂O. HL and its complexes were screened for their antibacterial and antifungal activity by agar diffusion method. The results of these studies showed that the metal complexes are more effective antibacterial and antifungal agents as compared with the free ligand. The anticancer activity was screened against human breast cancer cell line (MCF-7). Results indicated that metal complexes showed an increased cytotoxicity in proliferation to cell lines as compared to free ligand. Molecular docking studies were performed to identify the binding orientation or conformation of a complex in the active site of the protein. HL and its complexes were docked with crystal structure of DDB1 of breast cancer, crystal structure of HCV, RNA-dependent RNA polymerase, receptors of HBV core protein, crystal structure of the Fab fragment of anti-HAV.     

Coordination behaviour,molecular docking,density functional theory calculations and biological activity studies of some transition metal complexes of bis‐Schiff base ligand

Coordination compounds of Mn (II), Fe (III), Co (II), Ni (II), Cu (II) and Cd (II) ions were synthesized from reaction with Schiff base ligand 4,6‐bis((E)‐(2‐(pyridin‐2‐yl)ethylidene)amino)pyrimidine‐2‐thiol (HL) derived from the condensation of 4,6‐diaminopyrimidine‐2‐thiol and 2‐(pyridin‐2‐yl)acetaldehyde. Microanalytical data, magnetic susceptibility, infrared and ¹H NMR spectroscopies, mass spectrometry, molar conductance, powder X‐ray diffraction and thermal decomposition measurements were used to determine the structure of the prepared complexes. It was found that the coordination between metal ions and bis‐Schiff base ligand was in a molar ratio of 1:1, with formula [M (HL)(H₂O)₂] X_n (M = Mn (II), Co (II), Ni (II), Cu (II) and Cd (II), n = 2; Fe (III), n = 3). Diffuse reflectance spectra and magnetic susceptibility measurements suggested an octahedral geometry for the complexes. The coordination between bis‐Schiff base ligand and metal ions was through NNNN donor sites in a tetradentate manner. After preparation of the complexes, biological studies were conducted using Gram‐positive (B. subtilis and S. aureus) and Gram‐negative (E. coli and P. aeruginosa) organisms. Metal complexes and ligand displayed acceptable microbial activity against both types of bacteria.     

Synthesis,characterization, antifungal and antibacterial activities evaluation of copper (II), zinc (II) and cadmium (II) chloride and bromide complexes with new (E)-1-(3,4-dimethoxybenzylidene)-4-methylthiosemicarbazone ligand

The reactions of Cu (II), Zn (II) and Cd (II) chloride or bromide with (E)-1-(3,4-dimethoxybenzylidene)-4-methylthiosemicarbazone (MTSVT) lead to the formation of new complexes. They were characterized by spectroscopic studies: IR, ¹H and ¹³C NMR. The crystal structures of the compounds [MTSVT] ( L ), [ZnBr₂(MTSVT)₂] ( 2 ), [CdCl₂(MTSVT)₂] ( 3 ) and [CdBr₂(MTSVT)₂^.H₂O] ( 4 ) were determined by X-ray diffraction. For complexes 2 – 4 , the ion is coordinated through the sulfur atom. All compounds were tested for their antifungal activity against human pathogenic fungi Candida albicans and Aspergillus fumigatus, and for their antibacterial activity against Gram (+) Bacillus subtilis and Enterococcus faecalis as well as against Gram (−) bacteria such as Paracoccus yeei and Acinetobacter baumanii. The results indicated that the metal complexes exhibited a marked enhancement in antibacterial activity compared with the parent Schiff base.     

Metal complexes of novel Schiff base derived from iron sandwiched organometallic and 4‐nitro‐1,2‐phenylenediamine: Synthesis,characterization, DFT studies,antimicrobial activities and molecular docking

The condensation of 2‐acetylferrocene with 4‐nitro‐1,2‐phenylenediamine in a 1:1 molar ratio, resulting in formation of a novel bi‐dentate organometallic Schiff base ligand (L), (2‐(1‐((2‐amino‐5‐nitrophenyl)imino)ethyl)cyclopenta‐2,4‐dien‐1‐yl)(cyclopenta‐2,4‐dien‐1‐yl)iron. Also, its Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes have been synthesized. The stoichiometric ratios of the prepared compounds were estimated using elemental analysis (C, H, N, M), molar conductivity, FT‐IR, UV‐Vis, ¹H‐NMR, SEM and mass spectral analysis. Furthermore, their TG and DTG properties were studied. The geometrical structure of the complexes was found to be octahedral. From spectral analysis, the Schiff base coordinated to metal ions through the azomethine and amine groups. DFT‐based molecular orbital energy calculations of the synthesized ligand have been studied, in which the ligand was theoretically optimized. The Schiff base and its metal complexes have been screened for their antimicrobial activities against different bacterial and fungal species by using disc diffusion method. The anticancer activities of the ligand and its metal complexes have also been studied towards breast cancer (MCF‐7) and human normal melanocytes (HFB‐4) cell lines. Molecular docking was also used to identify the interaction between the Schiff base ligand and its Cd(II) complex with the active site of the receptors of breast cancer mutant oxidoreductase (PDB ID: 3HB5), crystal structure of Staphylococcus aureus (PDB ID: 3Q8U) and yeast‐specific serine/threonine protein phosphatase (PPZ1) of Candida albicans (PDB ID:5JPE).     

Fabrication of novel Fe (III), Co (II), Hg (II), and Pd (II) complexes based on water-soluble ligand (NaH2PH): structural characterization,cyclic voltammetric,powder X-ray diffraction,zeta potential,and biological studies

Sodium4-hydroxy-3-([2-picolinoylhydrazineylidene]methyl)benzenesulfonate (NaH₂PH) was synthesized as a novel water-soluble ligand, by the condensation of picolinohydrazide with sodium 3-formyl-4-hydroxybenzenesulfonate. The (NaH₂PH) ligand and its isolated Co (II), Fe (III), Hg (II), and Pd (II) complexes were analyzed by elemental analysis and characterized by spectroscopic (Fourier transform infrared spectroscopy, UV–visible, powder XRD, ¹H NMR,¹³C NMR, MS) and magnetic measurements. By comparing IR spectra of both ligand and the metal complexes, one can assume that the (NaH₂PH) ligand behaves as a bi-negative tetradentate (ONNO) in [Co (NaPH)(H₂O)₂].3H₂O, and a mono-negative tridentate (ONO) in [Fe (NaPH)Cl₂(H₂O)] complex, whereas in [Hg₂(NaPH)Cl₂(H₂O)] complex, (NaH₂PH) coordinates as a bi-negative pentadentate (ONNNO) ligand via deprotonated OH group of phenolic ring (C=N)_Py and (C=N*) coordinated to one of Hg (II) ion and the oxygen atom of enolic group and (C=N)_az group with the another Hg (II) ion. Moreover, (NaH₂PH) acts as bi-negative tridentate (ONO) ligand in [Pd (NaPH)(H₂O)].2H₂O complex. The geometries of complexes were suggested based on the UV–visible spectra, magnetic measurements and confirmed by applying discrete Fourier transform (DFT) optimization studies. The thermal fragmentation of both [Pd (NaPH)(H₂O)].2H₂O and [Co (NaPH)(H₂O)₂].3H₂O complexes was performed, and the kinetic and thermodynamic parameters were computed using the Coats–Redfern and Horowitz–Metzger methods. The redox behavior of divalent ions of cobalt and mercury were discussed by the cyclic voltammetry technique in the presence and absence of (NaH₂PH) ligand. Biological potencies of the ligand and its metal complexes were evaluated as antioxidants (ABTS and DPPH), anticancer, DNA, and antimicrobial (Staphylococcus aureus and Bacillus subtilis as Gram (+) bacteria, Escherichia coli and Pseudomonas aeruginosa as Gram (−) bacteria, and Candida albicans as fungi).     

Synthesis,spectroscopic, DFT,biological studies and molecular docking of oxovanadium (IV), copper (II) and iron (III) complexes of a new hydrazone derived from heterocyclic hydrazide

A new Schiff base hydrazone (Z)‐2‐(2‐aminothiazol‐4‐yl)‐N′‐(2‐hydroxy‐3‐methoxybenzylidene) acetohydrazide (H₂L) and its chelates [VO (HL)₂]·5H₂O, [Cu (HL)Cl(H₂O)]·2H₂O and [Fe(L)Cl(H₂O)₂]·3H₂O have been isolated and characterized using different physico‐chemical methods, for example infrared (IR), electron paramagnetic resonance (EPR), thermogravimetric analysis and DTG in the solid state, and ¹H‐NMR, ¹³C‐NMR and UV in solution. Magnetic and UV–visible measurements proposed that the coordination environments are square pyramidal, tetrahedral and octahedral geometries for oxovanadium (IV), Cu (II) and Fe (III), respectively. The ligand acts as mono‐negative NO towards oxovanadium (IV) and Cu (II) ions, and bi‐negative ONO for Fe (III) ion. The geometries of the ligand and its complexes were performed using Gaussian 9 program with density functional theory. The EPR spectral data of oxovanadium (IV) and Cu (II) chelates confirmed the mentioned geometries. The molecular modeling was done, and illustrated bond lengths, bond angles, molecular electrostatic potential, Mulliken atomic charges and chemical reactivity for the inspected compounds. Theoretical IR and ¹H‐NMR of the free ligand were calculated. Furthermore, thermodynamic and kinetic parameters for thermal decomposition steps were studied. Docking study of H₂L was applied against the proteins of both bacterial strains Staphylococcus aureus and Escherichia coli, as well as the protein of xanthine oxidase as antioxidant agent by Schrödinger suite program utilizing XP glide protocol. Furthermore, antimicrobial, antioxidant and DNA‐binding activities of the compounds have been carried out.     

Microwave synthesis,spectral studies,antimicrobial approach,and coordination behavior of antimony(III) and bismuth(III) compounds with benzothiazoline

The reaction of 2-hydroxy-N-phenylbenzamide with 2-aminobenzenethiol yielded 2-hydroxy-N-phenylbenzamidebenzothiazoline (H₂-Saly · BTZ/HO⋂N⋂SH). The reaction of H₂-Saly · BTZ with PhSbCl₂, SbCl₃, and BiCl₃ under varied reaction conditions (microwave, as well as conventional method) gave corresponding antimony( III) and bismuth(III) Schiff base compounds (substitution along with addition) in different coordination environments. These complexes were characterized by elemental analysis, IR and NMR (¹H and ¹³C) spectral studies. The ligand was found to bifunctional tridentate, as well as monodentate for different starting materials of metal (Sb/Bi), as well as for different reaction conditions, hence, suitable coordination environments and pseudotrigonal bipyramidal geometry for the antimony and bismuth complexes have been proposed. Their biological activities have also been checked against many fungi and bacteria. The complexes were found to be more toxic than the corresponding ligand. The article is published in the original. The article is published in the original.     

Synthesis and characterization of novel oxime-imine ligands and their heteronuclear ruthenium(III) complexes

Vicinal carbonyl oxime (HL¹) and oxime-imine (H₂L²) ligands and their mononuclear Ru(III) and Cu(II), heterodinuclear Ru(III)-Mn(II), Ru(III)-Ni(II), Ru(III)-Cu(II), and heterotrinuclear Ru(III)-Cu(II)-Ru(III) chelates were synthesized and characterized by elemental analysis, molar conductivity, IR, ESR, ICP-OES, magnetic moment measurements, and thermal analyses studies. The free ligands were also characterized by ¹H NMR spectra. The carbonyl-oxime ligand coordinates through the oxygen of =N-OH to form a six-membered chelate ring. The quadridentate tetraaza ligand (H₂L²) obtained by condensing of the bidentate ligand 1-p-diphenylmethane-2-hydroxyimino-2-(1-naphthylamino)-1-ethanone (HL¹) with 1,2-phenylenediamine coordinates with Ru(III) through its nitrogen donors in the equatorial position with the loss of one of the oxime protons and concomitant formation of an intramolecular hydrogen bond. Stoichiometric and spectral results of the metal complexes indicated that the metal: ligand ratios in the mononuclear complexes of the ligand (HL¹) were found to be 1: 2, while these ratios were 1: 1 in the mononuclear complexes of the ligand (H₂L²). The metal: ligand ratios of the dinuclear complexes were found to be 2: 1, and this ratio was 3: 2 in the trinuclear complex. The article is published in the original.     

Coordination compounds of some transition metal ions with new Schiff base ligand derived from dibenzoyl methane. Structural characterization,thermal behavior,molecular structure,antimicrobial, anticancer activity and molecular docking studies

Series of Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes were prepared with tetradentate Schiff base ligand derived by condensation of 2‐aminophenol with dibenzoylmethane. The novel Schiff base H₂L (2–2′‐((1Z,1Z’)‐(1,3‐diphenyl propane‐1,3 diylidene) bis (azanylylidene) diphenol) and its binary metal complexes were characterized by physicochemical procedures i.e. elemental analysis, FT‐IR, UV–Vis, thermal analyses (TGA/DTG), mass spectrometry, magnetic susceptibility and conductometric measurements. On the basis of these studies, an octahedral geometry for all these complexes was proposed expect Ni(II) complex which had tetrahedral geometry. Molar conductivity values revealed that the complexes were electrolytes except Mn(II), Zn(II) and Cd(II) complexes were non electrolytes. The ligand bound to the metal ions via two azomethine N and two phenolic OH as indicated from the IR and ¹H NMR spectral study. The molecular and electronic structures of H₂L and its zinc complex were optimized theoretically and the quantum chemical parameters were calculated. The antimicrobial activity against a number of bacterial organisms as Streptococcus pneumonia, Bacillus Subtilis, Pseudomonas aeruginosa and Escherichia coli and fungi as Aspergillus fumigates, Syncephalastrum racemosum, Geotricum candidum and Candida albicans by disk diffusion method were screened for the Schiff base and its complexes. The Cd(II) complex has potent antimicrobial activity. Anticancer activity of the Schiff base ligand and its metal complexes were evaluated in human cancer (MCF‐7 cells viability). The Cr(III) complex exhibited higher activity than other complexes and ligand. Molecular docking was used to predict the binding between Schiff base ligand (H₂L) and its Zn(II) complex and the receptors of RNA of amikacin antibiotic (4P20) and human‐DNA‐Topo I complex (1SC7). The docking study provided useful structural information for inhibition studies.     

Synthesis,spectral, DFT,and antimicrobial studies of tin(II) and lead(II) complexes with semicarbazone and thiosemicarbazones derived from (2-hydroxyphenyl)(pyrrolidin-1-yl)methanone

A new series of metal complexes [M(L)₂] (where M = Sn(II), Pb(II), and HL = semicarbazone, thiosemicarbazone or phenylthiosemicarbazone) have been prepared and characterized by elemental analysis, conductance measurements, molecular weight determinations, UV–visible, infrared, and nuclear magnetic resonance (¹H-, ¹³C-, and ¹¹⁹Sn-NMR) spectral studies. Elemental analysis of the metal complexes suggested 1 : 2 (metal–ligand) stoichiometry. Infrared spectra of the complexes agree with coordination to the metal through the nitrogen of the azomethine (>C=N?) and the oxygen/sulfur of the ketonic/thiolic group. Electronic spectra suggest a distorted tetrahedral geometry for all Schiff base complexes. The bond lengths, bond angles, highest occupied molecular orbital, lowest unoccupied molecular orbital, Mulliken atomic charges, and the lowest energy model structure of the complexes have been determined with DFT calculations. Representative Schiff base and its metal chelates have been screened for their in vitro antibacterial activity against four bacteria, Gram-positive (Bacillus cereus, Staphylococcus aureus) and Gram-negative (Escherichia coli, Klebsiella pneumoniae) and four strains of fungus (Penicillium chrysogenum, Aspergillus niger, Rhizopus nigricans, and Alternaria alternata). The metal chelates possess higher antimicrobial activity than the free ligands.     

Cyclometalated complexes containing ferrocenyl Schiff base: Preparation,characterization, DFT calculations,application in cancer and biological researches and MOE studies

A series of transition metal (II/III) complexes containing organometallic Schiff base ligand (H₂L) had been synthesized and characterized by using elemental analysis (C, H, N, M), molar conductivity, IR, UV–Vis, ¹H NMR and mass spectral analysis. Also, their TG and DTG behaviors were investigated. The ligand was prepared by condensation of 4-aminosalicylic acid with 2-acetylferrocene in 1:1 M ratio. The data of elemental analysis indicated that the prepared complexes were synthesized also in a 1:1 M ratio. The ligand behaved as neutral bidentate ligand that coordinated to metal ions through protonated O-phenolic and protonated carboxylic-OH groups. All complexes had octahedral structure. DFT calculations for H₂L ligand were determined with some parameters such as HOMO-LUMO energy gab, electronegativity and chemical hardness–softness. Antimicrobial activity of both H₂L Schiff base ligand and its metal complexes was tested against different strains of bacteria and fungi species. Furthermore, all compounds had been screened for their anticancer activities against breast cancer (MCF-7) cell line. [Cu(H₂L)(H₂O)₂Cl₂]·2H₂O complex had the lowest IC₅₀ value = 47.3 µg/mL. For determining the more effective and probable binding mode between the H₂L ligand, Co(II) and Zn(II) complexes with different active sites of 4K3V, 2YLB and 3DJD receptors, so molecular docking studies were investigated.     

Preparation,characterization and biological activity of novel metal-NNNN donor Schiff base complexes

Novel Schiff base (H₂L) ligand is prepared via condensation of benzil and triethylenetetraamine. The ligand is characterized based on elemental analysis, mass, IR and ¹H NMR spectra. Metal complexes are reported and characterized based on elemental analyses, IR, ¹H NMR, solid reflectance, magnetic moment, molar conductance, and thermal analyses (TG, DTG and DTA). 1:1 [M]:[H₂L] complexes are found from the elemental analyses data having the formulae [M(H₂L)Cl₂]·yH₂O (M = Mn(II), Co(II), Ni(II), Cu(II), Zn(II), Cd(II)), [Fe(H₂L)Cl₂]Cl·H₂O, [Th(H₂L)Cl₂]Cl₂·3H₂O and [UO₂(H₂L)](CH₃COO)₂·2H₂O. The metal chelates are found to be non-electrolytes except Fe(III), Th(IV) and UO₂(II) complexes are electrolytes. IR spectra show that H₂L is coordinated to the metal ions in a neutral tetradentate manner with 4Ns donor sites of the two azomethine N and two NH groups. The geometrical structures of these complexes are found to be octahedral. The thermal behaviour of these chelates is studied where the hydrated complexes lose water molecules of hydration in the first step followed immediately by decomposition of the anions and ligand molecules in the subsequent steps. The activation thermodynamic parameters are calculated using Coats–Redfern method. The ligand (H₂L), in comparison to its metal complexes, is screened for its antibacterial activity. The activity data show that the metal complexes have antibacterial activity more than the parent Schiff base ligand and cefepime standard against one or more bacterial species.